Stock SKAN SKAN GROUP AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings SKAN Group AG Berne S.E.

Equities

SKAN

CH0013396012

Delayed Berne S.E.
Other stock markets
 		5-day change 1st Jan Change
- CHF -.--% Intraday chart for SKAN Group AG -.--% -.--%
Mar. 26 Transcript : SKAN Group AG, 2023 Earnings Call, Mar 26, 2024
Mar. 26 Switzerland's SKAN Group Logs Improved FY23 Profit, Revenue MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 55% by 2026.
  • The company's profit outlook over the next few years is a strong asset.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Sales forecast by analysts have been recently revised upwards.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 45.32 times its estimated earnings per share for the ongoing year.
  • The company's enterprise value to sales, at 4.4 times its current sales, is high.
  • The company appears highly valued given the size of its balance sheet.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
SKAN GROUP AG Stock SKAN Group AG
-.--% 2.01B -
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+73.27% 12.38B
B-
PENUMBRA, INC. Stock Penumbra, Inc.
-21.89% 7.61B
C+
MASIMO CORPORATION Stock Masimo Corporation
+14.67% 7.11B
C-
GETINGE AB Stock Getinge AB
+4.77% 5.83B
B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+11.77% 5.35B
D+
APT MEDICAL INC. Stock APT Medical Inc.
+29.65% 4.63B -
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-19.09% 4.02B
B-
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-42.48% 2.16B
C
SHENZHEN YHLO BIOTECH CO., LTD. Stock Shenzhen YHLO Biotech Co., Ltd.
+4.85% 1.88B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SKAN Stock
  4. SKAN Stock
  5. Ratings SKAN Group AG